What Clover Corporation does

Clover Corporation Limited (ASX: CLV) is an Australian B2B supplier of specialty nutritional oils and microencapsulated ingredients, headquartered in Altona North, Melbourne. The company operates through its Nu-Mega sub-brand and serves global manufacturers in four end-markets: infant and children's nutrition, senior nutrition, sports and active nutrition, and functional beverages. Its portfolio comprises 22 products built around DHA, ARA, and Choline-XL ingredients, derived principally from tuna oil.

Clover's core technology is a patented microencapsulation process that enables the stable incorporation of oxidation-sensitive omega-3 oils into dry and solid food formats such as infant formula, powdered drinks, and dietary supplements. The company is vertically integrated through a wholly owned Ecuador tuna oil facility that now supplies 30% of raw material needs, and it holds a jointly controlled interest in Melody Dairies (New Zealand) for spray drying capacity. It also claims scientific credibility through a systematic review published in Critical Reviews in Food Science and Nutrition and the support of approximately 40% of clinical trials on fish oil products via Nu-Mega, with US GRAS status for its Pre-term Emulsion.

The business model is a B2B ingredient supply model, generating revenue from bulk product sales to manufacturers under negotiated, quote-based pricing. The go-to-market combines direct enterprise sales with a distributor network covering Europe, ANZ, Southeast Asia, Japan, Korea, China, and the USA. H1 FY26 revenue reached AUD 44.1 million, up 17.3% year-over-year, with management guiding to AUD 92-96 million for full-year FY26; gross margin expanded 850 basis points to 35.6% and NPAT grew 75% to AUD 4.2 million, reflecting margin recovery and operating leverage as the Ecuador facility and specialty diversification scaled.

Name

Clover Corporation

Legal name

Clover Corporation Limited

Website

https://clovercorp.com.au

Company type

Public

Founded year

1988

Operating status

Operating

Headcount range

11–50 employees

Short description

Clover Corporation (ASX: CLV) is a Melbourne-based B2B supplier of DHA, ARA, and Choline-XL nutritional oils and microencapsulated ingredients. It serves global infant formula, senior nutrition, sports nutrition, and functional beverage manufacturers through its Nu-Mega sub-brand.

Ownership category

akta.pro rank

Product category

Nutritional Oils and Microencapsulated Ingredients

NAICS

Fats and Oils Refining and Blending (311225), Starch and Vegetable Fats and Oils Manufacturing (31122)

SIC

Fats & Oils (2070), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids) (AFAJAKAC)

akta.pro secondary industries

Lipid-Based Emulsions & Encapsulated Oils (Spray-Dried Oils, Microencapsulation) (AFAJALAM), Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL), Baby Feeding Supplements & Fortifiers (Probiotics, DHA/ARA, Vitamins) (CRADAEAI)

Keywords

• Nutritional oils manufacturer
• Omega-3 ingredients supplier
• Microencapsulated DHA powders
• Infant formula ingredients
• B2B nutritional ingredients

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D

Revenue model

1. Nutritional Ingredients Product Sales: Clover generates revenue primarily through the sale of nutritional oils (DHA, ARA) and microencapsulated powder ingredients to manufacturers in the infant nutrition, senior nutrition, powdered drinks, and sports nutrition markets. Revenue is derived from a portfolio of 22 products with strategic diversification into higher-margin specialty categories driving margin expansion.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Clover Corporation manufactures and supplies nutritional oils and microencapsulated powder ingredients — principally DHA, ARA and Choline-XL — to infant formula, senior nutrition, sports nutrition and powdered drinks manufacturers worldwide. The portfolio of 22 products is enabled by the company's patented microencapsulation technology, which protects omega-3 oils from oxidation and enables stable delivery in dry and solid food formats, with raw material supplied in part by its company-owned Ecuador tuna oil facility.

Product overview

Clover Corporation operates primarily through its Nu-Mega sub-brand, offering a portfolio of nutritional oil ingredients and microencapsulation technology services. The company supplies DHA oils and DHA powders to the global infant, children, and medical food markets. Their core offerings center on Omega-3 fatty acids extracted from tuna, with proprietary microencapsulation technology enabling commercial delivery. The portfolio includes 22 products spanning infant formula, seniors nutrition, powdered drinks, and sports nutrition segments. A new product initiative called Premneo was recently introduced.

Differentiator

Problem solved

Functional benefit

Brands

• Nu-Mega: Science-based bioactives brand delivering benefits to global infant, children and medical food markets.
• Premneo

Products and services

• Nu-Mega Nutritional Ingredient Brand Clover's commercial business brand offering a portfolio of nutritional oils (DHA, ARA) and microencapsulated powder ingredients serving global infant, children and medical food manufacturers with science-based bioactives.
• DHA Oils Fish oil products containing high levels of omega-3 fatty acids, including DHA, supplied to nutritional product manufacturers for use in infant formula, senior nutrition and sports nutrition applications.
• DHA Powders Powdered formulations of DHA produced via Clover's patented microencapsulation technology for use in food, beverage, and nutritional supplement applications.
• ARA (Arachidonic Acid) Nutritional oil ingredient supplied for use in infant formula and pediatric nutritional applications, providing the omega-6 fatty acid arachidonic acid.
• Choline-XL Specialty ingredient included in Clover's higher-margin product diversification strategy, supplied for use in nutritional formulations targeting brain and cognitive development.
• Premneo New product line/brand within Clover's portfolio, with a dedicated product website (premneo.com). Specific product offerings under the Premneo brand had not yet been disclosed at the time of the source.

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• Melody DairiescoreStrategic or Co-development Partner · 5 November 2018Clover invested in Melody Dairies in New Zealand, adding spray drying capacity to its operations. The facility is now operating profitably following resolution of covenant issues, contributing to improved manufacturing performance and operational efficiency.
• Nu-Mega IngredientscoreOthersNu-Mega is Clover's commercial business unit, internationally recognized for collaboration with research institutions to scientifically validate the benefits of high DHA fish oil consumption. Nu-Mega has supported 40% of clinical trials on human and animals with fish oil products.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• dsm-firmenich: Global nutrition and health ingredients leader with a broad omega-3 (including DHA from algae and fish), ARA, and nutritional lipids portfolio serving infant formula, dietary supplements, and functional food manufacturers — directly overlapping with Clover's core product set but at vastly greater scale.
• BASF SE: Diversified chemical and nutrition company supplying omega-3 fatty acids (including DHA oils) and other nutritional lipids to infant formula and functional food manufacturers globally; competes with Clover on ingredient supply but with a much broader portfolio.
• Croda International: Specialty chemicals and consumer care ingredients supplier with a focused nutritional lipids business (including high-purity omega-3 concentrates) serving infant nutrition, dietary supplements, and personal care; comparable to Clover as a B2B nutritional lipid specialist at larger scale.

Direct peers

• Aker BioMarine: Norwegian krill-based omega-3 (EPA/DHA) ingredient supplier with Superba krill oil and similar encapsulated and oil products targeting human nutrition, including infant, sports, and senior nutrition — a direct peer in the marine-sourced omega-3 ingredients market.
• KD Pharma Group: Specialist in high-concentration omega-3 EPA/DHA oils and encapsulated powders serving nutritional supplement and infant formula manufacturers globally; competes with Clover in encapsulated omega-3 ingredient supply.
• GC Rieber Oils: Norwegian-based fish oil refiner producing refined EPA/DHA oils and specialty marine lipid ingredients for human nutrition, including infant formula; comparable to Clover's DHA oil and microencapsulated ingredient offering.
• Epax (Pelagia): Producer of high-concentration omega-3 EPA/DHA oils and encapsulated ingredients for nutraceutical and infant formula markets; directly comparable to Clover's refined DHA and microencapsulated powder portfolio.
• Bioriginal Food & Science Corp. Canadian supplier of omega-3 oils (including DHA-rich fish oils) and microencapsulated powders for the nutritional supplement, food, and beverage industries; closely comparable to Clover's ingredient and encapsulation offering.
• Royal DSM (now dsm-firmenich) Algae DHA supplier via Martek: Through its Martek heritage, dsm-firmenich supplies life'sDHA from algae — a competing DHA source used in infant formula alongside fish-oil-derived DHA, making it a direct substitute competitor in Clover's primary segment.

Regional players

• Stepan Company: US-headquartered specialty chemical and nutritional ingredient manufacturer with omega-3 lipid products serving the North American nutrition market; relevant peer given Clover's USA expansion, though with a primarily North American geographic focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/clover-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clover Corporation